Open AccessFirst-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study
Author(s) -
Viki Bockstal,
Georgi Shukarev,
Chelsea McLean,
Neil Goldstein,
Stephan Bart,
Auguste Gaddah,
Dickson Anumenden,
Jeroen N. Stoop,
Anne Marit de Groot,
Maria Grazia Pau,
Jenny Hendriks,
Stephen C. De Rosa,
Kristen W. Cohen,
M. Juliana McElrath,
Benoît Callendret,
Kerstin Lühn,
Macaya Douoguih,
Cynthia Robinson
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0274906
Subject(s) - ebola virus , ebola vaccine , chills , tolerability , myalgia , regimen , medicine , marburg virus , ebola hemorrhagic fever , modified vaccinia ankara , virology , placebo , adverse effect , randomized controlled trial , immunogenicity , vaccination , immunology , outbreak , vaccinia , biology , pathology , immune system , gene , biochemistry , alternative medicine , recombinant dna